blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0956867

EP0956867 - Use of flavonoid glycosides, tanning agents and microorganisms for the therapy and prophylaxis of diabetes mellitus [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.04.2001
Database last updated on 25.09.2024
Most recent event   Tooltip27.04.2001Application deemed to be withdrawnpublished on 13.06.2001 [2001/24]
Applicant(s)For all designated states
Liebel, Franz-Peter, Dr.
Am Petersberg 61
D-33619 Bielefeld / DE
[1999/46]
Inventor(s)01 / see applicant
...
[1999/46]
Application number, filing date98108560.812.05.1998
[1999/46]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0956867
Date:17.11.1999
Language:DE
[1999/46]
Search report(s)(Supplementary) European search report - dispatched on:EP06.02.1999
ClassificationIPC:A61K45/06, A61K31/70, A61K31/35, A61K35/78
[1999/46]
CPC:
A61K31/704 (EP); A61K31/22 (EP); A61K31/35 (EP);
A61K31/366 (EP); A61K31/404 (EP); A61K31/475 (EP);
A61K45/06 (EP) (-)
Designated contracting states(deleted) [2000/30]
Former [1999/46]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Verwendung von Flavonoidglykosiden, Gerbstoffen und Mikroorganismen zur Therapie und Prophylaxe des Diabetes mellitus[1999/46]
English:Use of flavonoid glycosides, tanning agents and microorganisms for the therapy and prophylaxis of diabetes mellitus[1999/46]
French:Utilisation de glycosides de flavonoides, de tanins et de microorganismes pour le traitement et la prophylaxie du diabète sucré[1999/46]
Examination procedure18.05.2000Application deemed to be withdrawn, date of legal effect  [2001/24]
06.12.2000Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2001/24]
Fees paidPenalty fee
Penalty fee Rule 85a EPC 1973
15.08.2000AT   M01   Not yet paid
15.08.2000CH   M01   Not yet paid
15.08.2000DE   M01   Not yet paid
15.08.2000FR   M01   Not yet paid
15.08.2000GB   M01   Not yet paid
Penalty fee Rule 85b EPC 1973
15.08.2000M01   Not yet paid
Additional fee for renewal fee
31.05.200003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0402049  (HAYASHIBARA BIOCHEM LAB) [X] 1,8 * page 6, line 4 - line 12; claims 17-19 *;
 [X]JPH03240725  ;
 [X]JPH0840923  ;
 [X]CN1124287  ;
 [X]JPH09187230  ;
 [X]JPH03232851
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 91, no. 49, Database accession no. 91-358398, XP002081613 & JPH03240725 A 19911028 (SENJU PHARM CO) [X] 1,8 * abstract *
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 96, no. 16, Database accession no. 96-157018, XP002081614 & JPH0840923 A 19960213 (NAKANO M) [X] 1,8 * abstract *
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 97, no. 47, Database accession no. 97-504325, XP002081615 & CN1124287 A 19960612 (SHU Z) [X] 1,8 * abstract *
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 97, no. 39, Database accession no. 97-419359, XP002081616 & JPH09187230 A 19970722 (NIPPON FLOUR MILLS CO LTD) [X] 1,8 * abstract *
 [X]  - CHERIAN S ET AL, "Antidiabetic effect of a glycoside of pelargonidin isolated from the bark of Ficus bengalensis Linn.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, XP002081612 [X] 1,8 * abstract *
    [ ] - INDIAN J BIOCHEM BIOPHYS, AUG 1992, 29 (4) P380-2, INDIA
 [X]  - JEAN T. ET AL, "Mediators involved in inflammation: Effects of Daflon 500 mg on their release", ANGIOLOGY, 1994, 45/6 SUPPL. (554-559), USA, XP002081607 [X] 1,8 * abstract *
 [X]  - LACOMBE C. ET AL, "Activity of Daflon 500 mg on the hemorheological disorders in diabetes", INT. ANGIOL., 1989, 8/4 SUPPL. (45-48), Italy, XP002081608 [X] 1,8 * abstract *
 [X]  - BEHAR A. ET AL, "Capillary filtration and lymphatic resorption in diabetes. Application to the pharmacodynamic activity of Daflon 500 mg", INT. ANGIOL., 1989, 8/4 SUPPL. (27-29), Italy, XP002081609 [X] 1,8 * page 29, column 2, paragraph 4 *
 [X]  - LACOMBE C. ET AL, "Hemorheological improvement after Daflon 500 mg treatment in diabetes", INT. ANGIOL., 1988, 7/2 SUPPL. (21-24), Italy, XP002081610 [X] 1,8 * page 23, column 2, paragraph 7 - page 24, column 1, paragraph 2 *
 [X]  - BOUSKELA E ET AL, "Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in diabetic hamsters.", INT J MICROCIRC CLIN EXP, NOV-DEC 1995, 15 (6) P293-300, SWITZERLAND, XP002081611 [X] 1,8 * abstract *
 [X]  - PATENT ABSTRACTS OF JAPAN, (19920114), vol. 016, no. 013, Database accession no. (C - 0901), & JP03232851 A 19911016 (NIPPON FLOUR MILLS CO LTD) [X] 1,8 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.